Evercore ISI analyst Robert Ottenstein raised the firm’s price target on Procter & Gamble to $183 from $177 and keeps an Outperform rating on the shares. P&G remains “a reliable durable grower,” says the analyst, who contends that Street expectations for Q4 and FY25 look conservative, even without a rebound in China, and are likely underestimating Procter’s operating leverage in a neutral commodity environment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $190 from $177 at Citi
- Procter & Gamble Unveils Stock Market Investment Strategies
- Savvy Shopping Habits Impact Staples Companies’ Profits
- Playtex maker ticks lower after UC Berkeley study on tampon toxins
- Arsenic and lead found in study measuring toxic metals in tampons